No Data
Pfizer, Arvinas Win FDA Nod For First-Of-Its-Kind Breast Cancer Therapy
Guardant Health Announces FDA Approval Of The Guardant360 CDx Liquid Biopsy Test As A Companion Diagnostic For VEPPANU
Express News | Guardant Health Receives FDA Approval for Guardant360® Cdx as a Companion Diagnostic for Arvinas and Pfizer’s Veppanu (Vepdegestrant) for Patients With Er+/Her2- Advanced Breast Cancer With Esr1 Mutations
William Blair Updates Conviction Stock List
Earnings Preview: GH to Report Financial Results Post-market on May 07
10 Health Care Stocks With Whale Alerts In Today's Session
PlsHelpUpMyStockHere : STMICROELECTRONICS remains strong.
102655916 :![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
AiBITclues27 : (BTMR) is so outdated.... it destroys EARNING and gains ... I love to feel the burn so when im winning it gotta feel like it![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
(
)
104088143 : What kind of
74167195 : could yo utell me when you go up ? lol
View more comments...